<SEC-DOCUMENT>0001564590-22-028600.txt : 20220809
<SEC-HEADER>0001564590-22-028600.hdr.sgml : 20220809
<ACCEPTANCE-DATETIME>20220809083056
ACCESSION NUMBER:		0001564590-22-028600
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220809
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220809
DATE AS OF CHANGE:		20220809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viracta Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001061027
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943295878
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51531
		FILM NUMBER:		221146643

	BUSINESS ADDRESS:	
		STREET 1:		2533 S COAST HWY 101
		STREET 2:		SUITE 210
		CITY:			CARDIFF
		STATE:			CA
		ZIP:			92007
		BUSINESS PHONE:		858-400-8470

	MAIL ADDRESS:	
		STREET 1:		2533 S COAST HWY 101
		STREET 2:		SUITE 210
		CITY:			CARDIFF
		STATE:			CA
		ZIP:			92007

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MOSAIC PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19980709

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUNESIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19980501
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>virx-8k_20220809.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-08-08T21:52:06.5548967+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : 16a160eeda874c22a838f2f97549b85e -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:virx="http://viracta.com/20220809" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
virx-8k_20220809.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001061027_20220809_20220809">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0001061027_20220809_20220809">0001061027</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="virx-20220809.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001061027_20220809_20220809">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001061027</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-08-09</xbrli:startDate>
					<xbrli:endDate>2022-08-09</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="text-align:center;border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">WASHINGTON, D.C. 20549</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001061027_20220809_20220809">8-K</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT</p>
<p style="text-align:center;margin-bottom:6pt;margin-top:9pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-right:0.37%;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001061027_20220809_20220809" format="ixt:datemonthdayyearen">August 9, 2022</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0001061027_20220809_20220809">VIRACTA THERAPEUTICS, INC.</ix:nonNumeric></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of Registrant as Specified in Its Charter)</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001061027_20220809_20220809" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0001061027_20220809_20220809">000-51531</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001061027_20220809_20220809">94-3295878</ix:nonNumeric></p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction<br />of Incorporation)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission File Number)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer<br />Identification No.)</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:20%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0001061027_20220809_20220809">2533 S. Coast Hwy. 101</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine2" contextRef="C_0001061027_20220809_20220809">Suite 210</ix:nonNumeric></p></td>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;width:59%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0001061027_20220809_20220809">Cardiff</ix:nonNumeric>, <ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0001061027_20220809_20220809" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0001061027_20220809_20220809">92007</ix:nonNumeric></p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Offices)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:41%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:9pt;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0.37%;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s Telephone Number, Including Area Code:<span style="font-weight:normal;"> </span><ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0001061027_20220809_20220809">(858)</ix:nonNumeric><span style="font-weight:normal;"> </span><ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0001061027_20220809_20220809">400-8470</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former Name or Former Address, if Changed Since Last Report)</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:WrittenCommunications" contextRef="C_0001061027_20220809_20220809" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
<tr>
<td valign="top" style="width:4.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:SolicitingMaterial" contextRef="C_0001061027_20220809_20220809" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
<tr>
<td valign="top" style="width:4.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementTenderOffer" contextRef="C_0001061027_20220809_20220809" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
<tr>
<td valign="top" style="width:4.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001061027_20220809_20220809" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:15%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Trading<br />Symbol(s)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0001061027_20220809_20220809">Common Stock,  par value $0.0001 per share</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:15%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:TradingSymbol" contextRef="C_0001061027_20220809_20220809">VIRX</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:45%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:SecurityExchangeName" contextRef="C_0001061027_20220809_20220809" format="ixt-sec:exchnameen">The NASDAQ Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter). </p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company <span style="font-family:Segoe UI Symbol;color:#000000;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001061027_20220809_20220809" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:MS Gothic;color:#000000;">&#9744;</span></p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 2.02 Results of Operations and Financial Condition.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 9, 2022, Viracta Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the fiscal quarter ended June 30, 2022. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All of the information furnished in this Item 2.02 and the press release attached hereto as Exhibit 99.1 shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01 Financial Statements and Exhibits.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">(d) Exhibits</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:91%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:8%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:91%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="top" style="width:8%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:91%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:91%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="d333166dex991.htm"><span style="text-decoration:underline;">Press Release, dated August 9, 2022</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:91%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:9pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:46%;">
<p style="margin-bottom:4pt;margin-top:4pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Viracta Therapeutics, Inc.</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August 9, 2022</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:46%; border-bottom:solid 0.75pt #000000;">
<p style="margin-top:4pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Daniel Chevallard</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;width:46%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:9pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Daniel Chevallard<br />Chief Operating Officer and Chief Financial Officer </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d333166dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head><META content="text/html; charset=utf-8"></META></head><body style="font-size:10pt;font-family:Arial;color:black;">
<blockquote>
  <div style="width:100%;margin-left:10pt">
    <div align="right"><b>Exhibit 99.1</b></div>
  </div>
</blockquote>
<div style="width:100%;margin-left:10pt">
  <p style="text-align:center"><b>Viracta Therapeutics Reports Second Quarter
    2022 Financial Results and Recent Updates</b></p>
</div>
<div style="width:100%;margin-left:10pt;"><div style="margin:0;margin-top:16pt;"><p style="text-align: center;"><i>Continued progress of NAVAL-1, the pivotal trial of Nana-val for the treatment of Epstein-Barr virus-positive (EBV<sup>+</sup>) lymphoma; update on the initial cohort(s) expanding into Stage 2 is anticipated in the fourth quarter of 2022</i></p><p style="text-align: center;"><i>Advanced the Phase 1b/2 trial of Nana-val in EBV<sup>+</sup> solid tumors into the second dose escalation cohort; </i><i>preliminary safety and efficacy data are anticipated in the fourth quarter of 2022</i></p><p style="text-align: center;"><i>Cash, cash equivalents and investments of $83.1 million as of June 30, 2022, provides projected runway into
mid-2024</i></p><p>SAN DIEGO, Aug. 9, 2022 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today reported financial results for the second quarter of 2022 and provided an update on recent corporate developments.</p><p>&#34;We are pleased with our corporate progress in the first half of 2022, having advanced both of our Nana-val clinical trials towards important milestones anticipated later this year, while maintaining a strong cash position that provides a projected runway into the middle of 2024,&#34; said Ivor Royston, M.D., President and Chief Executive Officer of Viracta. &#34;The Phase 1b/2 trial in EBV-positive solid tumors is now enrolling patients in the second dose escalation cohort, and we are on track to report preliminary data in the fourth quarter. For the pivotal NAVAL-1 trial in EBV-positive
lymphoma, we incorporated an important amendment into our clinical trial protocol, which allows for the evaluation of Nana-val as a second-line therapy in patients with EBV-positive peripheral T-cell lymphoma. Now, both T-cell lymphoma subtypes in NAVAL-1, extranodal NK/T-cell and peripheral T-cell, are enrolling second-line patients. We believe this is an acknowledgment of the high unmet medical need in T-cell lymphoma and the strength of our data to date.&#34;</p><p><b>Second Quarter 2022 and Recent Highlights</b></p><p><b><i>Clinical</i></b></p><ul type="disc"><li><b>Amended the protocol for NAVAL-1, the pivotal trial of Nana-val in relapsed/refractory EBV<sup>+ </sup>lymphoma to enable enrollment of second-line peripheral T-cell lymphoma patients. </b>The recently enacted protocol amendment is designed to enable the evaluation of Nana-val as an earlier therapeutic option, as the
protocol previously required patients in this cohort be third-line or later. NAVAL-1 employs a Simon two-stage design with Stage 1 enrolling patients into six cohorts based on lymphoma subtype. If a pre-specified activity threshold is reached, additional patients will be enrolled in Stage 2. Lymphoma subtypes demonstrating promising activity in Stage 2 may be further expanded. If successful, Viracta believes NAVAL-1 could potentially support multiple new drug application filings across various EBV<sup>+ </sup>lymphoma subtypes. The trial has sites open globally, including in the U.S., Canada, Europe, and Asia. An update on the initial cohort(s) that may advance into Stage 2 of the trial is anticipated in the fourth quarter of 2022.</li><li><b>Advanced to the second dose escalation cohort within the Phase 1b part of the Phase 1b/2 trial of Nana-val in patients with EBV<sup>+</sup>
recurrent/metastatic nasopharyngeal carcinoma (R/M NPC) and other EBV<sup>+</sup> solid tumors. </b>Initiation of the second dose escalation cohort followed a favorable review of safety data from the first dose escalation cohort by the trial&#39;s independent Safety Monitoring Committee, which noted no dose-limiting toxicities in the trial to date. Enrollment is ongoing in the second dose cohort of the trial&#39;s Phase 1b portion, which is designed to evaluate safety and determine the recommended Phase 2 dose (RP2D) of Nana-val in patients with EBV<sup>+</sup> R/M NPC. In Phase 2 of the trial, up to 60 patients with EBV<sup>+</sup> R/M NPC will be randomized to receive Nana-val at the RP2D with or without pembrolizumab to evaluate safety and preliminary efficacy. The trial also includes a Phase 1b dose expansion cohort designed to evaluate Nana-val at the RP2D in patients with other
EBV<sup>+</sup> solid tumors. Preliminary safety and efficacy data from the Phase 1b dose escalation portion of the trial are anticipated in the fourth quarter of 2022.</li></ul><p><b><i>Corporate and Thought Leadership </i></b></p><ul type="disc"><li><b>Dr. Royston honored with the Science History Institute&#39;s Biotechnology Heritage Award. </b>First bestowed in 1999, the Award honors extraordinary individuals whose work in biotechnology is helping to heal, fuel, and feed the world through discovery, innovation, commercialization, or public understanding. It was presented to Dr. Royston by the Science History Institute alongside the Biotechnology Innovation Organization (BIO), which represents more than 1,200 biotech companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other nations.</li><li><b>Hosted
key opinion leader (KOL) webinar on Nana-val for the treatment of advanced EBV<sup>+ </sup>solid tumors. </b>During the webinar, KOL Ezra Cohen, M.D., FRCPSC, FASCO (University of California, San Diego) and members of the Viracta management team discussed the current treatment landscape and unmet medical need in NPC, the design of the Phase 1b/2 trial of Nana-val in advanced EBV<sup>+</sup> solid tumors, and preclinical data supporting the trial. A replay of the webinar is available here.</li></ul><p><b><i>Scientific Presentations</i></b></p><ul type="disc"><li><b>Highlighted the design of the Phase 1b/2 trial of Nana-val in advanced EBV<sup>+</sup> solid tumors in a poster at the American Society of Clinical Oncology (ASCO) Annual Meeting. </b>The poster was presented by A. Dimitrios Colevas, M.D. (Stanford Cancer Institute), during a session titled, &#34;Head and Neck Cancer.&#34; A
copy of the poster is available here.</li><li><b>Presented an overview of the Company&#39;s novel &#34;<i>Kick and Kill</i>&#34; approach to targeting EBV-associated malignancies at the 20<sup>th</sup> International Symposium on EBV and Associated Diseases. </b>The presentation was delivered by Viracta&#39;s Chief Scientific Officer, Dr. Ayman Elguindy, and included previously announced data demonstrating Nan-val&#39;s mechanism of action and anti-cancer activity. The symposium was sponsored by the International Association for Research on Epstein-Barr Virus and Associated Diseases.</li></ul><p><b>Anticipated 2022 Milestones</b></p><ul type="disc"><li>Provide preliminary Phase 1b safety and efficacy data from the Phase 1b/2 trial in advanced EBV<sup>+</sup> solid tumors: Q4 2022</li><li>Update on NAVAL-1 cohort(s) that may progress from Stage 1 to Stage 2: Q4 2022</li></ul><p><b>Second
Quarter 2022 Financial Results</b></p><ul type="disc"><li><b>Cash position &#8211; </b>Cash, cash equivalents and short-term investments totaled approximately $83.1 million as of June 30, 2022, which Viracta expects will be sufficient to fund its operations into mid-2024, excluding any incremental borrowing under its previously announced $50.0 million credit facility from Silicon Valley Bank and Oxford Finance.</li><li><b>Research and development expenses &#8211; </b>Research and development expenses were approximately $6.3 million and $12.4 million for the three and six months ended June 30, 2022, respectively, compared to approximately $5.4 million and $9.5 million for the same periods in 2021. The increase in research and development expenses was primarily due to increases in costs incurred to support the advancement and expansion of our clinical development programs, including
incremental costs to support NAVAL-1, our pivotal trial in R/R EBV<sup>+</sup> lymphoma, and the initiation of our Phase 1b/2 trial for the treatment of EBV<sup>+</sup> solid tumors, as well as an increase in headcount and non-cash share-based compensation.</li><li><b>Acquired in-process research and development &#8211; </b>The acquired in-process research and development for the six months ended June 30, 2021 included non-cash and non-recurring cost of $84.5 million associated with the estimated fair value of the in-process research and development projects acquired in the asset acquisition with no alternative future use, which was charged to expense upon the completion of the transaction in February 2021.</li><li><b>General and administrative expenses &#8211; </b>General and administrative expenses were approximately $4.2 million and $8.5 million for the three and six months ended
June 30, 2022, respectively, compared to approximately $3.9 million and $7.7 million for the same periods in 2021. The change was primarily driven by an increase in non-cash share-based compensation.</li><li><b>Gain on royalty purchase agreement &#8211; </b>The gain on royalty purchase agreement for the six months ended June 30, 2021, was associated with upfront proceeds of $13.5 million recorded in connection with the multi-license milestone and royalty monetization transaction with XOMA (US) LLC.</li><li><b>Adjusted loss from operations &#8211; </b>There was not a comparative adjustment to loss from operations for the quarters ended June 30, 2022, and 2021. There was not a comparative adjustment to loss from operations for the six months ended June 30, 2022. Adjusted loss from operations for the six months ended June 30, 2021, excluding the non-recurring and non-cash operating
expenses associated with the write-off of in-process research and development acquired in the merger (a non-GAAP measure) was $3.7 million, compared to an unadjusted loss from operations of $88.2 million.</li><li><b>Net loss &#8211; </b>Net loss was approximately $10.6 million, or $0.28 per share (basic and diluted) for the quarter ended June 30, 2022, compared to a net loss of $9.2 million or $0.25 per share (basic and diluted) for the same period in 2021. Net loss was approximately $21.1 million, or $0.56 per share (basic and diluted) for the six months ended June 30, 2022, compared to a net loss of $88.4 million or $3.37 per share (basic and diluted) for the same period in 2021.</li></ul><p><b>About Nana-val (Nanatinostat and Valganciclovir)</b></p><p>Nanatinostat is an orally available histone deacetylase (HDAC) inhibitor being developed by Viracta. Nanatinostat is selective for
specific isoforms of Class I HDACs, which is key to inducing viral genes that are epigenetically silenced in Epstein-Barr virus (EBV)-associated malignancies. Nanatinostat is currently being investigated in combination with the antiviral agent valganciclovir as an all-oral combination therapy, Nana-val, in various subtypes of EBV-associated malignancies. Ongoing trials include a pivotal, global, multicenter, open-label Phase 2 basket trial in multiple subtypes of relapsed/refractory EBV<sup>+ </sup>lymphoma (NAVAL-1) as well as a multinational Phase 1b/2 trial in patients with EBV<sup>+</sup> recurrent or metastatic nasopharyngeal carcinoma and other EBV<sup>+</sup> solid tumors.</p><p><b>About EBV-Associated Cancers</b></p><p>Approximately 90% of the world&#39;s adult population is infected with Epstein-Barr virus (EBV). Infections are commonly asymptomatic or associated with
mononucleosis. Following infection, the virus remains latent in a small subset of lymphatic cells for the duration of the patient&#39;s life. Cells containing latent virus are increasingly susceptible to malignant transformation. Patients who are immunocompromised are at an increased risk of developing EBV<sup>+ </sup>lymphomas. EBV is estimated to be associated with approximately 2% of the global cancer burden including lymphoma, nasopharyngeal carcinoma and gastric cancer.</p><p><b>About Viracta Therapeutics, Inc.</b></p><p>Viracta is a precision oncology company targeting virus-associated malignancies. Viracta&#39;s lead product candidate is an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir (collectively referred to as Nana-val). Nana-val is currently being evaluated in multiple ongoing clinical trials,
including a pivotal, global, multicenter, open-label Phase 2 basket trial for the treatment of multiple subtypes of relapsed/refractory Epstein-Barr virus-positive (EBV<sup>+</sup>) lymphoma (NAVAL-1), as well as a multinational Phase 1b/2 trial for the treatment of EBV<sup>+ </sup>recurrent or metastatic nasopharyngeal carcinoma and other EBV<sup>+</sup> solid tumors. Viracta is also pursuing the application of its inducible synthetic lethality approach in other virus-related cancers.</p><p>For additional information please visit www.viracta.com.</p><p><b>Forward-Looking Statements </b></p><p>This communication contains &#34;forward-looking&#34; statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding: the details, timeline and expected progress for Viracta&#39;s ongoing trials and updates regarding the
same; the anticipated 2022 milestones and key upcoming events and their significance; and other statements that are not historical facts. Risks and uncertainties related to Viracta that may cause actual results to differ materially from those expressed or implied in any forward-looking statement include, but are not limited to: Viracta&#39;s ability to successfully enroll patients in and complete its ongoing and planned clinical trials; Viracta&#39;s plans to develop and commercialize its product candidates, including all oral combinations of nanatinostat and valganciclovir; the timing of initiation of Viracta&#39;s planned clinical trials; the timing of the availability of data from Viracta&#39;s clinical trials; previous preclinical and clinical results may not be predictive of future clinical results; the timing of any planned investigational new drug application or new drug
application; Viracta&#39;s plans to research, develop and commercialize its current and future product candidates; the clinical utility, potential benefits and market acceptance of Viracta&#39;s product candidates; Viracta&#39;s ability to manufacture or supplying nanatinostat, valganciclovir and pembrolizumab for clinical testing; Viracta&#39;s ability to identify additional products or product candidates with significant commercial potential; developments and projections relating to Viracta&#39;s competitors and its industry; the impact of government laws and regulations; Viracta&#39;s ability to protect its intellectual property position; and Viracta&#39;s estimates regarding future expenses, capital requirements and need for additional financing in the future.</p><p>These risks and uncertainties may be amplified by the COVID-19 pandemic, which has caused significant economic
uncertainty. If any of these risks materialize or underlying assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption &#34;Risk Factors&#34; and elsewhere in Viracta&#39;s reports and other documents that Viracta has filed, or will file, with the SEC from time to time and available at www.sec.gov.</p><p>The forward-looking statements included in this communication are made only as of the date hereof. Viracta assumes no obligation and does not intend to update these forward-looking statements, except as required by law or applicable regulation.</p><p><b>Investor Relations Contact:
<br /></b>Ashleigh Barreto
<br />Head of Investor Relations &amp; Corporate Communications
<br />Viracta Therapeutics, Inc.
<br />abarreto@viracta.com</p><p> </p><div><div><table style="border-collapse: collapse; border: 1pt none black;" border="0" cellspacing="0" cellpadding="0"><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Viracta Therapeutics, Inc.</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt;
font-family: Arial; color: black;"><b>Selected Balance Sheet Highlights</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(in thousands)</i></b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>June 30,</b></font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>December 31,</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2022</b></font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2021</b></font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(Unaudited)</i></b></font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Cash and cash equivalents and short-term investments</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">83,145</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size:
8pt; font-family: Arial; color: black;">103,554</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Total assets</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">89,155</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size:
8pt; font-family: Arial; color: black;">108,552</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Total liabilities</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">12,152</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size:
8pt; font-family: Arial; color: black;">14,181</font></font></p></td></tr><tr><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1" nowrap><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Stockholders&#39; equity</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">77,003</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1" nowrap>
<br /></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="removeWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" nowrap><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size:
8pt; font-family: Arial; color: black;">94,371</font></font></p></td></tr></table></div></div><p> </p><div><div><table style="border-collapse: collapse; border: 1pt none black;" border="0" cellspacing="0" cellpadding="0"><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Viracta Therapeutics, Inc.</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Condensed Consolidated Statement of Operations and Comprehensive Loss</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(in thousands except share and per share data)</i></b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(Unaudited)</i></b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="5" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Three Months Ended June 30,</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="4" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Six Months Ended June 30,</b></font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2022</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2021</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2022</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2021</b></font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial;
color: black;">Operating expenses:</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Research and development</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">6,324</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">5,446</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">12,420</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">9,470</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Acquired in-process research and development</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">84,478</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">General and administrative</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">4,181</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">3,871</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">8,517</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">7,711</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Total
operating expenses</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">10,505</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">9,317</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">20,937</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">101,659</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Gain on Royalty Purchase
Agreement</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">13,500</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">Loss from operations</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(10,505)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(9,317)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(20,937)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(88,159)</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Total other income
(expense)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(77)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">147</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(191)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(242)</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Net loss and
comprehensive loss</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(10,582)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">(9,170)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">(21,128)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">(88,401)</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Net loss per share, basic and diluted</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font
style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(0.28)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">(0.25)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">(0.56)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">(3.37)</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Weighted-average common shares
<br />outstanding, basic and diluted</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">37,599,244</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">37,221,407</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">37,567,734</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 0.5pt 1pt 1pt; border-style: solid none none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">26,255,992</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Viracta Therapeutics, Inc.</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Reconciliation of GAAP Loss from Operations to Adjusted (Loss) Income from Operations</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(in thousands)</i></b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: center;" colspan="6" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b><i>(Unaudited)</i></b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="4" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Three Months Ended June 30,</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="4" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>Six Months Ended June 30,</b></font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2022</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2021</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2022</b></font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: center;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;"><b>2021</b></font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Loss from operations</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">(10,505)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">(9,317)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">(20,937)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">(88,159)</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 24px; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: left;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">Less: Acquired in-process research and development</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">&#8212;</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt 1pt 0.5pt; border-style: none none solid; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1" align="right"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">84,478</font></font></p></td></tr><tr><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom;" colspan="1" rowspan="1"><p style="margin: 0px 0pt 0px 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">Adjusted loss from operations</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font
style="font-size: 8pt; font-family: Arial; color: black;">(10,505)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">(9,317)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">(20,937)</font></font></p></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; font-size: 8pt; font-family: Arial; color: black; margin: 0in;" colspan="1" rowspan="1">
<br /></td><td class="AddWrap" style="padding-right: 4px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color: black;">$</font></font></p></td><td class="AddWrap" style="padding-right: 1px; padding-left: 2pt; border-width: 1pt; border-style: none; border-color: black; vertical-align: bottom; text-align: right;" colspan="1" rowspan="1"><p style="margin-top: 0px; margin-bottom: 0px; margin-left: 3.8px; font-size: 8pt; font-family: Arial; color: black;"><font style="font-family:Arial;font-size:8pt;color:black"><font style="font-size: 8pt; font-family: Arial; color:
black;">(3,681)</font></font></p></td></tr></table></div></div><p> </p><p> </p>
<br /><br />
    <p><a href="g333166logo.jpg"><img src="g333166logo.jpg" title="viracta_therapeutics_inc_log.jpg" width="400" height="110" border="0"></a></p>
    <p>   </p></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g333166logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333166logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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MDJ'2%B0S.4-B<I25T1@T1%1S@I/!&1IC@]0E)I:QPO_$ !P!  ,! 0$! 0$
M           &!P@%! ,! O_$ $41  $!!00&!P,)!P0#      $"  ,$!1$&
M$B$Q!T%187&!$Q0B-9&AP14RL1<C-D)B<G.RT5)4@I+A\/$6)-+B,Z*S_]H
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M4+M"#0^\-;1]_P#'LWFOSSLW_P".0OW*9;T(F^9M WT]AN87O:%=8EVN-HR
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MW5HLV\PPQG&=ANZWD+3HY#;*?XO$/AY-"B5#XQQSP%3"J&VPG?7XTI=GYM&
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MN7V\>E<U?K'=SN>?YBV6K?\ ?\1Q3^5+.GZLW[U+/OI>?N,:LB]8/_FX[O\
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MG^Z2_P#H+_RISO5H(KL3=BVA!UIQHG*TD!:"DG^),>-,@]CV/B6OU!6]IA#
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>0W;PI6]6G_JWCD6C,2Z.=QHB+UPUI=I7#;>+?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>virx-20220809.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-08-08T21:52:06.5548967+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : 16a160eeda874c22a838f2f97549b85e -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:virx="http://viracta.com/20220809" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://viracta.com/20220809" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" namespace="http://xbrl.sec.gov/currency/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" namespace="http://xbrl.sec.gov/exch/2022" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" namespace="http://xbrl.sec.gov/sic/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" namespace="http://fasb.org/srt-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" namespace="http://fasb.org/srt-types/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" namespace="http://fasb.org/us-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://viracta.com/20220809/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="virx-20220809_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="virx-20220809_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>virx-20220809_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-08-08T21:52:06.5548967+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : 16a160eeda874c22a838f2f97549b85e -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>virx-20220809_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-08-08T21:52:06.5548967+00:00 -->
<!-- Version            : 5.0.1.747 -->
<!-- Package ID         : 16a160eeda874c22a838f2f97549b85e -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://viracta.com/20220809/role/TemplateLink" xlink:href="virx-20220809.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="virx-20220809.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139889904638272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  09,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIRACTA THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001061027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3295878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2533 S. Coast Hwy. 101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cardiff<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">400-8470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock,  par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VIRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>virx-8k_20220809_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="virx-20220809.xsd" xlink:type="simple"/>
    <context id="C_0001061027_20220809_20220809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001061027</identifier>
        </entity>
        <period>
            <startDate>2022-08-09</startDate>
            <endDate>2022-08-09</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001061027_20220809_20220809" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001061027_20220809_20220809" id="F_000004">0001061027</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001061027_20220809_20220809" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001061027_20220809_20220809" id="F_000002">2022-08-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001061027_20220809_20220809" id="F_000003">VIRACTA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001061027_20220809_20220809" id="F_000007">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001061027_20220809_20220809" id="F_000006">000-51531</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001061027_20220809_20220809" id="F_000008">94-3295878</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001061027_20220809_20220809" id="F_000009">2533 S. Coast Hwy. 101</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001061027_20220809_20220809" id="F_000010">Suite 210</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001061027_20220809_20220809" id="F_000011">Cardiff</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001061027_20220809_20220809" id="F_000012">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001061027_20220809_20220809" id="F_000013">92007</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001061027_20220809_20220809" id="F_000014">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001061027_20220809_20220809" id="F_000015">400-8470</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001061027_20220809_20220809" id="F_000016">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001061027_20220809_20220809" id="F_000017">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001061027_20220809_20220809" id="F_000018">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001061027_20220809_20220809" id="F_000019">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001061027_20220809_20220809" id="F_000020">Common Stock,  par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001061027_20220809_20220809" id="F_000021">VIRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001061027_20220809_20220809" id="F_000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001061027_20220809_20220809" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ UD,)59>*NQS
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M=1,92L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3
MQFU+BLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=
MR_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D
M&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&
ML&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @
MUD,)520>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ UD,)50=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #60PE5,USR
M,>\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " #60PE5F5R<(Q &  "<)P  $P              @ '- 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -9#"57<$%*!;P0  #L1
M   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " #60PE5GZ ;\+$"  #B#   #0              @ &S#
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -9#"567BKL<P    !,"   +
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4!08     "0 ) #X"   3%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="virx-8k_20220809.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="virx-8k_20220809.htm">virx-8k_20220809.htm</File>
    <File>d333166dex991.htm</File>
    <File>virx-20220809.xsd</File>
    <File>virx-20220809_lab.xml</File>
    <File>virx-20220809_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "virx-8k_20220809.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "virx-8k_20220809.htm"
     ]
    },
    "labelLink": {
     "local": [
      "virx-20220809_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "virx-20220809_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "virx-20220809.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "virx",
   "nsuri": "http://viracta.com/20220809",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "virx-8k_20220809.htm",
      "contextRef": "C_0001061027_20220809_20220809",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "virx-8k_20220809.htm",
      "contextRef": "C_0001061027_20220809_20220809",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://viracta.com/20220809/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-22-028600-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-028600-xbrl.zip
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M_8.*72]UQ?NAC-U(9JGR$G$C(QVGB;B5H&!?_"MS8[A>&"G:S79;_*1"-_1
M1W!MD@5PK0L7WD@<6?P6^6XJ$R-,1 )8019;.>BZ>J5Y^ZR97Y?JZ*QU;"Z;
M)ITPXN';ZO(:C*K"3/HBBO4@EDDB=%^\N?IP]6J_Y8AT*$6D[G0*DJ1H<WK7
M#=W]._B]KV.Z(HVEFXY0-'CW192D$I;QHQO'XD[%6;(?Z42EZDZ*W1<_?KA(
MLNCR_RX.\,>>",:C:*A'[KG(2"M"AS2D"N$3,(6GAZ#JW61/R$\1Z%"% W@O
MU>(V=0=2M(5"U8)55 2?]N$]^GA?9W$Z%']8R\"RT"P7!XHT_KA:KOP[L!^,
MAX.]&[J)%*W>07N*#F#"":%$H@,%G\Q&.D[,8G&4Q(#%US"63#PW<%,%PAH!
MSP6M35U&L0S4"- 3@QNZ?9F."3FRWU>>ZXT%Z,@5;BR_AM#7;C)TA ?_"OE'
MID Z>-,@5X5W,B$3$SZ^/SULM 0P08 BN/3:/[-0BL.F0Y,Z"*<[Y<L$?_E=
M>KC,. OOW;'1R/;62/G[<&FG7-_E[=4;\?SEBY_?.N(J&S1$UPPF#M[=O)'W
MR;V*Y8'8WQ?3G-(1+T.O(7;?N(GO_G$F/KR\^<^>(UR87WHJP77J$ EK, :=
MCP!+8Y&"P\@4(65PZB:)!J?%M8Y(/^C#$H9.M0\+C\GMX<U^X=VQ]>[<$ZR1
M)TQ *K0*\>&/"M9C0PF>CF%L?,V7=S+0$:FZ8?7RPW>'G?-_2[)[%$A HR_N
M%9@:#%[Y:.'!.1Y4G*1BZ ;]?"$._'6'\KHYOGL:A^G32 6FO0#<S\M=/@'Q
M[]W8AW%'J ! 'IH>\*!#6?<^P+1$18!3CJ4;.^)^"!>",L'F\#_-#"B,-?Q"
M.#/,0#[OIB5FW!FH0:D -SZ,:23J.*0;<!7PN)=W8(4;/<:%.>)UXWG#$>]
M(3 D+!EM<#U4$ACJD_0RXJ.WZ%;&3A93#4$#OI_F]L;52S:K^WDB0GTO9!AK
M\ J0#S2BR%^L->;ZOT/+NS<F1G7 8CZ"WBWF1)46B *FNGQ#_&1QF'.V)?(9
M FQOY?3KX-PJ++!$*"W-[0(<?2)X,@/!KH81M%>JP;W(Y-X0PGB@[TN_D "K
MS A<)4\736T4LP_C2;P6/!JM7>J/D%Y;=R1C%>&5@7B_[\D@*,)(0[S1]XY!
M]<1;(LEZZ3B29) BP $5QFX([@VZ^O7 ?H3<=7(.AVQ3VK>Z['RM#0%>V@-3
M@1,;-Z#P),"8 (Y ^H,\2J)2AI#CB"P<2? GZ9,R0VGH?'+MN"("$83:<%"Z
M+&$!+()TTB#D6LJ U&4B.RF(R&8AO\#L 69912)B/H:!P-K64+-],P-3@_J>
M[?@J\2!>! JOOD)DV#B98X"LOF *H9 " S<"2CN(91]]4 /&BY J3$PM% &R
MRM#M!;DE<GW6K#$3'A5#H5SHY8: @S$.2WQ32%$!?0*TG$ \0$&+!3R"ZU
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ML<#B@<S3ET46;8\(DZJH!I"0TZ?F5<O%-&<(;A;86'N'Y> T Y?/DJ+(A8Z
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M=M"T3SYQYND/ZJD>)N HY8^([;LT]MW>6LS"MW12#[GQCVY M8_;H90/GV/
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M^WX7@'4?436"$?B3DO-X#(/=!(OE:0@/A+@ V%M(-(5Y"Z8RBS_IB3#WG"\
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M.# Y+GAS9%!+ 0(4 Q0    ( -9#"55$)X(*% <  .=+   5
M  "  2DF  !V:7)X+3(P,C(P.# Y7VQA8BYX;6Q02P$"% ,4    " #60PE5
MQY^I5 0%   (+0  %0              @ %P+0  =FER>"TR,#(R,#@P.5]P
M<F4N>&UL4$L! A0#%     @ UD,)522EB?KD$   UI(  !0
M ( !IS(  '9I<G@M.&M?,C R,C X,#DN:'1M4$L%!@     %  4 1@$  +U#
$      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
